Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice.

A P Sachs, G H Koëter, K H Groenier, D van der Waaij, J Schiphuis, B Meyboom-de Jong

Department of Family Practice, University of Groningen, The Netherlands.

BACKGROUND--Bacterial infections of the lower airways during an exacerbation in patients with asthma or chronic obstructive pulmonary disease (COPD) may be the cause of an exacerbation or the consequence of a viral infection or an increase in airways limitation. To determine whether bacterial infection is an important component in the pathogenesis of an exacerbation, the effects of antimicrobial treatment must be studied. METHODS--Patients with asthma or COPD seen in general practice were studied in a double blind randomised manner to investigate whether the antimicrobial drugs amoxicillin (500 mg three times daily), cotrimoxazole (960 mg twice daily), or a placebo, each when added to a short course of oral corticosteroids, can accelerate recovery from exacerbations. Patients were instructed to contact their own physician early in the morning when complaints of increased shortness of breath, wheezing, or exacerbations of cough with or without sputum production occurred. Treatment effects were evaluated over the next 14 days by studying symptom scores (wheeze, dyspnoea, cough with and without mucus production, and awakening with dyspnoea), peak expiratory flow values (PEF, expressed as % predicted), and sublingual temperature. Bacteriological study of the sputum was made at the onset of an exacerbation and 7, 21 and 35 days afterwards. RESULTS--Of 195 patients enrolled 71 (36%) contacted their physician for symptoms of an exacerbation. Symptoms improved in all three groups, improvements ranging from 0.54 to 0.75 points per day on a four point scale. PEF% predicted showed improvements in the three groups after the exacerbation, ranging from 0.34% to 0.78% predicted per day, finally returning to baseline values. Sublingual temperature did not change. Six of 71 patients consulted their physician because of a relapse between four and 24 days after the start of treatment. In only two of the 50 sputum samples, collected during an exacerbation, and which contained > or = 10(5) bacteria in culture sensitive to the chosen antibiotic given, did any benefit from antimicrobial treatment occur. During the recovery period sputum purulence improved irrespective of antibiotic treatment. CONCLUSIONS--Antibiotics given with a short course of oral prednisolone during an exacerbation do not accelerate recovery as measured by changes in peak flow and symptom scores in ambulatory patients with mild to moderate asthma or COPD when treated by their general practitioners. Moreover, antibiotics do not reduce the number of relapses after treating an exacerbation.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Roede, B. M., Bresser, P., Prins, J. M., Schellevis, F., Verheij, T. J. M., Bindels, P. J. E. (2009). Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD. Eur Respir J 33: 282-288 [Abstract] [Full Text]  
• Korbila, I. P., Manta, K. G., Siempos, I. I., Dimopoulos, G., Falagas, M. E. (2009). Penicillins vs trimethoprim-based regimens for acute bacterial exacerbations of chronic bronchitis: Meta-analysis of randomized controlled trials. cfp 55: 60-67 [Abstract] [Full Text]  
• Wedzicha, J. A (2008). Antibiotics at COPD exacerbations: the debate continues. Thorax 63: 940-942 [Full Text]  
• Roede, B M, Bresser, P, Bindels, P J E, Kok, A, Prins, M, Riet, G t., Geskus, R B, Herings, R M C, Prins, J M (2008). Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study. Thorax 63: 968-973 [Abstract] [Full Text]  
• Miravitlles, M. (2007). Review: Do we need new antibiotics for treating exacerbations of COPD?. Ther Adv Respir Dis 1: 61-76 [Abstract]  
• Stolz, D., Christ-Crain, M., Bingisser, R., Leuppi, J., Miedinger, D., Muller, C., Huber, P., Muller, B., Tamm, M. (2007). Antibiotic Treatment of Exacerbations of COPD: A Randomized, Controlled Trial Comparing Procalcitonin-Guidance With Standard Therapy. Chest 131: 9-19 [Abstract] [Full Text]  
• O'Donnell, D E, Parker, C M (2006). COPD exacerbations {middle dot} 3: Pathophysiology.. Thorax 61: 354-361 [Abstract] [Full Text]  
• Hurst, J R, Wedzicha, J A (2004). Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation. Postgrad. Med. J. 80: 497-505 [Abstract] [Full Text]  
• Sethi, S. (2004). Bacteria in Exacerbations of Chronic Obstructive Pulmonary Disease: Phenomenon or Epiphenomenon?. Proc Am Thorac Soc 1: 109-114 [Abstract] [Full Text]  
• White, A J, Gompertz, S, Stockley, R A (2003). Chronic obstructive pulmonary disease * 6: The aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax 58: 73-80 [Abstract] [Full Text]  
• Weinberger, M., Murray, M. D., Marrero, D. G., Brewer, N., Lykens, M., Harris, L. E., Seshadri, R., Caffrey, H., Roesner, J. F., Smith, F., Newell, A. J., Collins, J. C., McDonald, C. J., Tierney, W. M. (2002). Effectiveness of Pharmacist Care for Patients With Reactive Airways Disease: A Randomized Controlled Trial. JAMA 288: 1594-1602 [Abstract] [Full Text]  
• Miravitlles, M. (2002). Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?. Eur Respir J 20: 9S-19s [Abstract] [Full Text]  
• Ewig, S. (2002). Legionella spp. in acute exacerbations of chronic obstructive pulmonary disease: what is the evidence?. Eur Respir J 19: 387-389 [Full Text]  
• Hirschmann, J. V. (2002). Antibiotics for Common Respiratory Tract Infections in Adults. Arch Intern Med 162: 256-264 [Abstract] [Full Text]  
• Woolhouse, I S, Hill, S L, Stockley, R A (2001). Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis. Thorax 56: 947-953 [Abstract] [Full Text]  
• Glauber, J. H., Fuhlbrigge, A. L., Finkelstein, J. A., Homer, C. J., Weiss, S. T. (2001). Relationship Between Asthma Medication and Antibiotic Use. Chest 120: 1485-1492 [Abstract] [Full Text]  
• Gompertz, S., O'Brien, C., Bayley, D.L., Hill, S.L., Stockley, R.A. (2001). Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 17: 1112-1119 [Abstract] [Full Text]  
• Wilson, R. (2001). Bacteria, antibiotics and COPD. Eur Respir J 17: 995-1007 [Abstract] [Full Text]  
• Bach, P. B., Brown, C., Gelfand, S. E., McCrory, D. C. (2001). Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Summary and Appraisal of Published Evidence. ANN INTERN MED 134: 600-620 [Abstract] [Full Text]  
• McCrory, D. C., Brown, C., Gelfand, S. E., Bach, P. B. (2001). Management of Acute Exacerbations of COPD : A Summary and Appraisal of Published Evidence. Chest 119: 1190-1209 [Abstract] [Full Text]  
• Georgopoulos, A., Borek, M., Ridl, W., Amoxycillin Bronchitis Study Group, T. (2001). Randomized, double-blind, double-dummy study comparing the efficacy and safety of amoxycillin 1 g bd with amoxycillin 500 mg tds in the treatment of acute exacerbations of chronic bronchitis. J Antimicrob Chemother 47: 67-76 [Abstract] [Full Text]  
• Hirschmann, J. V. (2000). Do Bacteria Cause Exacerbations of COPD?. Chest 118: 193-203 [Abstract] [Full Text]  
• SEEMUNGAL, T. A. R., DONALDSON, G. C., BHOWMIK, A., JEFFRIES, D. J., WEDZICHA, J. A. (2000). Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 161: 1608-1613 [Abstract] [Full Text]  
• Miravitlles, M., Espinosa, C., Fernandez-Laso, E., Martos, J. A., Maldonado, J. A., Gallego, M. (1999). Relationship Between Bacterial Flora in Sputum and Functional Impairment in Patients With Acute Exacerbations of COPD. Chest 116: 40-46 [Abstract] [Full Text]  
• Fabbri, L., Beghé, B., Caramori, G., Papi, A., Saetta, M. (1998). Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease. Thorax 53: 803-808 [Full Text]  
• Rutman, A., Dowling, R., Wills, P., Feldman, C., Cole, P. J., Wilson, R. (1998). Effect of Dirithromycin on Haemophilus influenzae Infection of the Respiratory Mucosa. Antimicrob. Agents Chemother. 42: 772-778 [Abstract] [Full Text]